F. Esma

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

A. Palumbo, P. Sonneveld, P. Galieni, 2018, Leukemia.

Melphalan hydrochloride for the treatment of multiple myeloma

M. Boccadoro, A. Larocca, R. Troia, 2017, Expert opinion on pharmacotherapy.

A Randomized Study of Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Cyclophosphamide-Dexamethasone Induction in Newly Diagnosed Myeloma Patients Eligible for Transplant: High Efficacy in High- and Standard-Risk Patients

P. Galieni, M. Boccadoro, E. Zamagni, 2017 .

Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study

P. Sonneveld, M. Boccadoro, G. Gaidano, 2017 .

In vitro antibacterial activity of Pituranthos scoparius from Algeria

A. Houria, F. Esma, D. Rabah, 2014 .